U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrati...
WASHINGTON - U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices - sometimes by more than 1,000% - and stifle competition for generic drugs, state prosecutors said on Saturday.
The 20 drug companies engaged in illegal conspiracies to divide up the market for drugs to avoid competing and, in some cases, conspired to either prevent prices from dropping or to raise them, according to the complaint by 44 U.S. states, filed on Friday in the U.S. District Court in Connecticut. The 500-page lawsuit accuses the generic drug industry, which mainly sells medicines that are off patent and should be less expensive, of a long history of discreet agreements to ensure that companies that are supposedly competitors each get a “fair share.
The lawsuit also names 15 individuals as defendants who it said carried out the schemes on a day-to-day basis. The lawsuit seeks damages, civil penalties and actions by the court to restore competition to the generic drug market. However, it added, “Prices for hundreds of generic drugs have risen – while some have skyrocketed, without explanation, sparking outrage from politicians, payers and consumers across the country whose costs have doubled, tripled, or even increased 1,000% or more.”
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
U.S. states accuse Teva, other drugmakers, of price-fixing -lawsuitU.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrati...
Consulte Mais informação »
Teva, other drug companies accused in sweeping U.S. price-fixing scheme: lawsuitU.S. states filed a lawsuit accusing 20 drug companies including Teva Pharmaceut...
Consulte Mais informação »
States allege generic drug executives deleted texts, obstructed justice in price cartel probeConnecticut has been leading an antitrust investigation into Teva and other companies.
Consulte Mais informação »
Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptionsEli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Ph...
Consulte Mais informação »
U.S. states accuse Teva, other drugmakers, of price-fixing -lawsuitU.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrati...
Consulte Mais informação »
Teva, other drug companies accused in sweeping U.S. price-fixing scheme: lawsuitU.S. states filed a lawsuit accusing 20 drug companies including Teva Pharmaceut...
Consulte Mais informação »
APNewsBreak: Drugmakers will have to reveal prices in TV adsWASHINGTON (AP) — Drugmakers will be required to reveal the prices of their prescription medicines in those ever present TV ads, the Trump administration is set to announce on Wednesday, even as...
Consulte Mais informação »
Trump administration orders drugmakers to disclose prices in TV adsThe Department of Health and Human Services finalized a rule Wednesday that would require disclosure of a drug’s cost if the price before rebates and discounts is above $35 for a month’s supply or the usual course of therapy.
Consulte Mais informação »
Drugmakers need to take a chill pill over new price-disclosure requirementThe Department of Health and Human Services finalized a rule Wednesday that would require drugmakers to disclose a drug’s cost in TV ads.
Consulte Mais informação »
Drugmakers will have to reveal prices in TV adsThe change is in response to a public outcry for government action to restrain medication costs.
Consulte Mais informação »